A New Take on BMT and Cellular Therapies

Oncology Advances

Just six years ago, CCTI principal investigator, Markus Mapara, MD, PhD joined New York-Presbyterian/Columbia University Irving Medical Center to build a collaborative clinical and translational oriented blood and marrow transplant (BMT) and cell therapy program from the ground up. Now Dr. Mapara, along with his innovative partners, Ran Reshef, MD and Pawel Muranski, MD discuss their work, the expansion of the program, the array of treatment options and what they hope to acheive with their cutting-edge research. Find the full story here.